Creekwood Pharmaceuticals
FDA Approved Drugs

Creekwood Pharmaceuticals

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX Unclassified
  • Total Records 33
  • Latest Approval Date Jun 16, 2026
  • Data Source FDA
  • First Approval Date Jan 27, 1996
All
33
View
Unclassified
4
View
RX
29
View
Company Overview

Company

Creekwood Pharmaceuticals

Country

U.S.A

Website

Visit Website

Email

drugsafety@creekwoodpharma.com

Social Profiles

Company Snapshot

Creekwood Pharmaceuticals

1130 Route 46 W, Parsippany, NJ 07054

U.S.A

creekwoodpharma.com/ drugsafety@creekwoodpharma.com View on Map
FDA Approved Drug Records ( 33 records )
2026
16 Jun
RX Application: 218875

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2026-06-16

218875 / 1

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

218875

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2026-06-16

Regulatory Status

RX

2026
16 Jun
RX Application: 218875

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 18MG BASE

Approval Date

2026-06-16

218875 / 2

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

218875

Product Number

2

Dosage Form

-

Strength

EQ 18MG BASE

Approval Date

2026-06-16

Regulatory Status

RX

2026
16 Jun
RX Application: 218875

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2026-06-16

218875 / 3

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

218875

Product Number

3

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2026-06-16

Regulatory Status

RX

2026
16 Jun
RX Application: 218875

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2026-06-16

218875 / 4

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

218875

Product Number

4

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2026-06-16

Regulatory Status

RX

2026
16 Jun
RX Application: 218875

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

5

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

2026-06-16

218875 / 5

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

218875

Product Number

5

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

2026-06-16

Regulatory Status

RX

2026
16 Jun
RX Application: 218875

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

6

Dosage Form

-

Strength

EQ 80MG BASE

Approval Date

2026-06-16

218875 / 6

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

218875

Product Number

6

Dosage Form

-

Strength

EQ 80MG BASE

Approval Date

2026-06-16

Regulatory Status

RX

2026
16 Jun
RX Application: 218875

Drug Name

ATOMOXETINE HYDROCHLORIDE

Product Number

7

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2026-06-16

218875 / 7

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Application Number

218875

Product Number

7

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2026-06-16

Regulatory Status

RX

2023
07 Sep
RX Application: 217732

Drug Name

FENOFIBRATE

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

2023-09-07

217732 / 1

Active Ingredient

FENOFIBRATE

Application Number

217732

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

2023-09-07

Regulatory Status

RX

2023
07 Sep
RX Application: 217732

Drug Name

FENOFIBRATE

Product Number

2

Dosage Form

-

Strength

120MG

Approval Date

2023-09-07

217732 / 2

Active Ingredient

FENOFIBRATE

Application Number

217732

Product Number

2

Dosage Form

-

Strength

120MG

Approval Date

2023-09-07

Regulatory Status

RX

2025
18 Dec
RX Application: 218162

Drug Name

HALOPERIDOL

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

2025-12-18

218162 / 1

Active Ingredient

HALOPERIDOL

Application Number

218162

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

2025-12-18

Regulatory Status

RX

2025
18 Dec
RX Application: 218162

Drug Name

HALOPERIDOL

Product Number

2

Dosage Form

-

Strength

1MG

Approval Date

2025-12-18

218162 / 2

Active Ingredient

HALOPERIDOL

Application Number

218162

Product Number

2

Dosage Form

-

Strength

1MG

Approval Date

2025-12-18

Regulatory Status

RX

2025
18 Dec
RX Application: 218162

Drug Name

HALOPERIDOL

Product Number

3

Dosage Form

-

Strength

2MG

Approval Date

2025-12-18

218162 / 3

Active Ingredient

HALOPERIDOL

Application Number

218162

Product Number

3

Dosage Form

-

Strength

2MG

Approval Date

2025-12-18

Regulatory Status

RX

2025
18 Dec
RX Application: 218162

Drug Name

HALOPERIDOL

Product Number

4

Dosage Form

-

Strength

5MG

Approval Date

2025-12-18

218162 / 4

Active Ingredient

HALOPERIDOL

Application Number

218162

Product Number

4

Dosage Form

-

Strength

5MG

Approval Date

2025-12-18

Regulatory Status

RX

2025
18 Dec
RX Application: 218162

Drug Name

HALOPERIDOL

Product Number

5

Dosage Form

-

Strength

10MG

Approval Date

2025-12-18

218162 / 5

Active Ingredient

HALOPERIDOL

Application Number

218162

Product Number

5

Dosage Form

-

Strength

10MG

Approval Date

2025-12-18

Regulatory Status

RX

2025
18 Dec
RX Application: 218162

Drug Name

HALOPERIDOL

Product Number

6

Dosage Form

-

Strength

20MG

Approval Date

2025-12-18

218162 / 6

Active Ingredient

HALOPERIDOL

Application Number

218162

Product Number

6

Dosage Form

-

Strength

20MG

Approval Date

2025-12-18

Regulatory Status

RX

1996
27 Jan
RX Application: 40150

Drug Name

HYDROXYCHLOROQUINE SULFATE

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

1996-01-27

40150 / 1

Active Ingredient

HYDROXYCHLOROQUINE SULFATE

Application Number

40150

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

1996-01-27

Regulatory Status

RX

2026
07 Apr
RX Application: 220269

Drug Name

NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)

Product Number

1

Dosage Form

-

Strength

75MG;25MG

Approval Date

2026-04-07

220269 / 1

Active Ingredient

NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE

Application Number

220269

Product Number

1

Dosage Form

-

Strength

75MG;25MG

Approval Date

2026-04-07

Regulatory Status

RX

2020
23 Mar
RX Application: 213423

Drug Name

PREGABALIN

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2020-03-23

213423 / 1

Active Ingredient

PREGABALIN

Application Number

213423

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2020-03-23

Regulatory Status

RX

2020
23 Mar
RX Application: 213423

Drug Name

PREGABALIN

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2020-03-23

213423 / 2

Active Ingredient

PREGABALIN

Application Number

213423

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2020-03-23

Regulatory Status

RX

2020
23 Mar
RX Application: 213423

Drug Name

PREGABALIN

Product Number

3

Dosage Form

-

Strength

75MG

Approval Date

2020-03-23

213423 / 3

Active Ingredient

PREGABALIN

Application Number

213423

Product Number

3

Dosage Form

-

Strength

75MG

Approval Date

2020-03-23

Regulatory Status

RX

2020
23 Mar
RX Application: 213423

Drug Name

PREGABALIN

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

2020-03-23

213423 / 4

Active Ingredient

PREGABALIN

Application Number

213423

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

2020-03-23

Regulatory Status

RX

2020
23 Mar
RX Application: 213423

Drug Name

PREGABALIN

Product Number

5

Dosage Form

-

Strength

150MG

Approval Date

2020-03-23

213423 / 5

Active Ingredient

PREGABALIN

Application Number

213423

Product Number

5

Dosage Form

-

Strength

150MG

Approval Date

2020-03-23

Regulatory Status

RX

2020
23 Mar
RX Application: 213423

Drug Name

PREGABALIN

Product Number

6

Dosage Form

-

Strength

200MG

Approval Date

2020-03-23

213423 / 6

Active Ingredient

PREGABALIN

Application Number

213423

Product Number

6

Dosage Form

-

Strength

200MG

Approval Date

2020-03-23

Regulatory Status

RX

2020
23 Mar
RX Application: 213423

Drug Name

PREGABALIN

Product Number

7

Dosage Form

-

Strength

225MG

Approval Date

2020-03-23

213423 / 7

Active Ingredient

PREGABALIN

Application Number

213423

Product Number

7

Dosage Form

-

Strength

225MG

Approval Date

2020-03-23

Regulatory Status

RX

2020
23 Mar
RX Application: 213423

Drug Name

PREGABALIN

Product Number

8

Dosage Form

-

Strength

300MG

Approval Date

2020-03-23

213423 / 8

Active Ingredient

PREGABALIN

Application Number

213423

Product Number

8

Dosage Form

-

Strength

300MG

Approval Date

2020-03-23

Regulatory Status

RX

-
Unclassified Application: 219460

Drug Name

PROPRANOLOL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

60MG

Approval Date

-

219460 / 1

Active Ingredient

PROPRANOLOL HYDROCHLORIDE

Application Number

219460

Product Number

1

Dosage Form

-

Strength

60MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219460

Drug Name

PROPRANOLOL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

80MG

Approval Date

-

219460 / 2

Active Ingredient

PROPRANOLOL HYDROCHLORIDE

Application Number

219460

Product Number

2

Dosage Form

-

Strength

80MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219460

Drug Name

PROPRANOLOL HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

120MG

Approval Date

-

219460 / 3

Active Ingredient

PROPRANOLOL HYDROCHLORIDE

Application Number

219460

Product Number

3

Dosage Form

-

Strength

120MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219460

Drug Name

PROPRANOLOL HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

160MG

Approval Date

-

219460 / 4

Active Ingredient

PROPRANOLOL HYDROCHLORIDE

Application Number

219460

Product Number

4

Dosage Form

-

Strength

160MG

Approval Date

-

Regulatory Status

Unclassified

2012
31 Dec
RX Application: 202047

Drug Name

RIZATRIPTAN BENZOATE

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2012-12-31

202047 / 1

Active Ingredient

RIZATRIPTAN BENZOATE

Application Number

202047

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2012-12-31

Regulatory Status

RX

2012
31 Dec
RX Application: 202047

Drug Name

RIZATRIPTAN BENZOATE

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2012-12-31

202047 / 2

Active Ingredient

RIZATRIPTAN BENZOATE

Application Number

202047

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2012-12-31

Regulatory Status

RX

2022
03 Jan
RX Application: 213230

Drug Name

SILODOSIN

Product Number

1

Dosage Form

-

Strength

4MG

Approval Date

2022-01-03

213230 / 1

Active Ingredient

SILODOSIN

Application Number

213230

Product Number

1

Dosage Form

-

Strength

4MG

Approval Date

2022-01-03

Regulatory Status

RX

2022
03 Jan
RX Application: 213230

Drug Name

SILODOSIN

Product Number

2

Dosage Form

-

Strength

8MG

Approval Date

2022-01-03

213230 / 2

Active Ingredient

SILODOSIN

Application Number

213230

Product Number

2

Dosage Form

-

Strength

8MG

Approval Date

2022-01-03

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    33 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
33 total
  • RX
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ATOMOXETINE HYDROCHLORIDE

Application Number

218875

Product Number

1

Active Ingredient

ATOMOXETINE HYDROCHLORIDE

Dosage Form

-

Strength

EQ 10MG BASE

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit